Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Smoldering”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03951220
What this trial is testing

The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

Who this might be right for
MyelomaMonoclonal Gammopathy of Undetermined Significance (MGUS)Smouldering Myeloma
Oxford University Hospitals NHS Trust 67
Testing effectiveness (Phase 2)Study completedNCT01302886
What this trial is testing

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
Novartis Pharmaceuticals 41
Not applicableLooking for participantsNCT05361694
What this trial is testing

Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
University of Miami 1,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05767359
What this trial is testing

CAR- PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 20
Testing effectiveness (Phase 2)Ended earlyNCT01965834
What this trial is testing

Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Miami 6
Testing effectiveness (Phase 2)Looking for participantsNCT06762769
What this trial is testing

Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma

Who this might be right for
Smouldering Myeloma
University College, London 63
Testing effectiveness (Phase 2)Active Not RecruitingNCT05014646
What this trial is testing

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma in African-American and European-American Patients

Who this might be right for
Smoldering Plasma Cell Myeloma
City of Hope Medical Center 27
Very early researchActive Not RecruitingNCT02603887
What this trial is testing

Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 20
Early research (Phase 1)Looking for participantsNCT06768489
What this trial is testing

JNJ-79635322 in Combination With Daratumumab With or Without Lenalidomide for Multiple Myeloma, Newly Diagnosed AL Amyloidosis, and High-risk Smoldering Multiple Myeloma or JNJ-79635322 in Combination With Pomalidomide for Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaImmunoglobulin Light-chain Amyloidosis
Janssen Research & Development, LLC 240
Testing effectiveness (Phase 2)Study completedNCT02316106
What this trial is testing

Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 123
Testing effectiveness (Phase 2)Active Not RecruitingNCT03236428
What this trial is testing

Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma

Who this might be right for
Monoclonal GammopathySmoldering Multiple Myeloma
Dana-Farber Cancer Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT05597345
What this trial is testing

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
University of Rochester 15
Early research (Phase 1)Study completedNCT01718899
What this trial is testing

Phase 1/2a Study of Cancer Vaccine to Treat Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
OncoPep, Inc. 22
Not applicableLooking for participantsNCT02726750
What this trial is testing

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 200
Testing effectiveness (Phase 2)WithdrawnNCT01571726
What this trial is testing

Imaging Studies and the Development of Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI)
Not applicableActive Not RecruitingNCT04023747
What this trial is testing

Oxford Pre-cancerous Lymphoproliferative Disorders Study

Who this might be right for
Pre-cancerous Lymphoproliferative Disorders
University of Oxford 574
Testing effectiveness (Phase 2)Active Not RecruitingNCT04850846
What this trial is testing

Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 60
Not applicableLooking for participantsNCT05640843
What this trial is testing

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 180
Not applicableLooking for participantsNCT03717844
What this trial is testing

Registry for Adults With Plasma Cell Disorders (PCD's)

Who this might be right for
Multiple MyelomaAmyloidosisCryoglobulinemia+6 more
UNC Lineberger Comprehensive Cancer Center 2,000
Not applicableLooking for participantsNCT02269592
What this trial is testing

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Who this might be right for
Monoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more
Dana-Farber Cancer Institute 10,000
Next Page